0.00
—
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Minerva Surgical
Its shares trade under the ticker UTRS. It has been listed since 22 October 2021. In the fiscal year to 31 December 2023, it reported revenue of $51.7m and a net loss of $33.5m.
Minerva Surgical, Inc. is a medical technology company, which engages in the research, development, manufacture, and commercialization of invasive solutions for uterine healthcare needs of women. The company is headquartered in Redwood City, California. The company went IPO on 2021-10-22. The firm has established a product line of commercially available, minimally invasive alternatives to hysterectomy, which are designed to address the most common causes of abnormal uterine bleeding (AUB) in most uterine anatomies. Its solutions can be used in a variety of medical treatment settings and aim to address the drawbacks associated with alternative treatment methods and to preserve the uterus by avoiding unnecessary hysterectomies. The firm offers a suite of products for the treatment of structural and non-structural causes of AUB in most uterine anatomies. Its devices are utilized by obstetrician-gynecologists (OB/GYNs) across a variety of medical treatment settings, including hospitals, ambulatory surgical centers (ASCs) and physician offices.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Listed since
- 22 Oct 2021
- Employees
- 157
- Website
- minervasurgical.com ↗
Leadership
Pay as last reported
- Dr. Uri GeigerNon-Executive Chairman of the Board
- Mr. Todd UsenPresident, Chief Executive Officer, Director, since 2023
- Mr. Joel JungChief Financial Officer, since 2021$558,921
- Mr. Dominique FillouxChief Operating Officer$548,321
- Dr. Evgueni SkalnyiVice President of Medical Affairs
- Ms. Kaile ZaggerChief Commercial Officer
- Dr. Ali BehbahaniIndependent Director$179,999
- Mr. Daniel CohenIndependent Director
- Ms. Catherine CosteIndependent Director$187,499
- Ms. Niquette HuntIndependent Director$164,999
- Dr. Derrick SungIndependent Director$222,499
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Minerva Surgical Inc employs 157 full-time employees in Redwood City, California.
- The company's product line offers minimally invasive alternatives to hysterectomy for uterine healthcare needs.
- Minerva Surgical Inc's devices are utilized by OB/GYNs in hospitals, ASCs, and physician offices.
Weaknesses
- The company went public on 22 October 2021 with a limited product line.
- Minerva Surgical Inc has no established presence in international markets beyond the US.
- The firm's focus on uterine healthcare limits its market scope to a specific medical segment.
Opportunities
- Expanding into international markets could increase Minerva Surgical Inc's global reach.
- Developing new products for non-structural causes of AUB may broaden the company's offerings.
- The growing demand for minimally invasive procedures presents a significant opportunity.
Threats
- The US healthcare sector faces increasing regulatory scrutiny affecting medical device companies.
- Competition from established medical device firms could challenge Minerva Surgical Inc's market position.
- A decline in demand for uterine healthcare solutions might impact the company's revenue.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.